Login / Signup

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure.

Emma K FlanaganPeter R GibsonJacob BegunSimon GhalyMayur GargJane M AndrewsOurania RosellaGennaro RosellaSally J Bell
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • ulcerative colitis
  • patients with inflammatory bowel disease
  • low birth weight
  • adverse drug
  • drug induced
  • preterm birth